From the Korean Hereditary Breast Cancer study [11] performed in Korea, one BRCA2 pathogenic variant (c.7480C>T) was identified as the Korean founder mutation using data from over 3,000 breast cancer patients [12]. This evidence concerns the gene BRCA2 and breast carcinoma.